LV5803B4 - Heterocikliskie atvasinajumi to iegusanas panemiens un to terapeitiska izmantosana par PAF-antagonistu - Google Patents
Heterocikliskie atvasinajumi to iegusanas panemiens un to terapeitiska izmantosana par PAF-antagonistuInfo
- Publication number
- LV5803B4 LV5803B4 LV960269A LV960269A LV5803B4 LV 5803 B4 LV5803 B4 LV 5803B4 LV 960269 A LV960269 A LV 960269A LV 960269 A LV960269 A LV 960269A LV 5803 B4 LV5803 B4 LV 5803B4
- Authority
- LV
- Latvia
- Prior art keywords
- alkyl
- acquisition
- therapeutic use
- heterocyclic derivatives
- paf antagonist
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8917491A FR2656610B1 (fr) | 1989-12-29 | 1989-12-29 | Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique. |
| EP91902715A EP0462264B1 (fr) | 1989-12-29 | 1990-12-28 | Derives heterocycliques, leur procede de preparation et leur application therapeutique comme antagonistes du paf |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LV5803A4 LV5803A4 (lv) | 1997-02-20 |
| LV5803B4 true LV5803B4 (lv) | 1997-08-20 |
Family
ID=9389177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LV960269A LV5803B4 (lv) | 1989-12-29 | 1996-07-18 | Heterocikliskie atvasinajumi to iegusanas panemiens un to terapeitiska izmantosana par PAF-antagonistu |
Country Status (31)
| Country | Link |
|---|---|
| US (5) | US5470855A (lv) |
| EP (1) | EP0462264B1 (lv) |
| JP (1) | JP2758077B2 (lv) |
| KR (1) | KR0159517B1 (lv) |
| CN (1) | CN1028757C (lv) |
| AT (1) | ATE119160T1 (lv) |
| AU (1) | AU627103B2 (lv) |
| BR (1) | BR1100202A (lv) |
| CA (1) | CA2046883C (lv) |
| CZ (1) | CZ280803B6 (lv) |
| DE (1) | DE69017443T2 (lv) |
| DK (1) | DK0462264T3 (lv) |
| ES (1) | ES2069276T3 (lv) |
| FI (1) | FI95380C (lv) |
| FR (1) | FR2656610B1 (lv) |
| HK (1) | HK1000011A1 (lv) |
| HU (2) | HU213230B (lv) |
| IE (1) | IE67322B1 (lv) |
| IL (1) | IL96811A (lv) |
| LV (1) | LV5803B4 (lv) |
| MX (1) | MX9203019A (lv) |
| NO (1) | NO179975C (lv) |
| NZ (1) | NZ236678A (lv) |
| PL (1) | PL167101B1 (lv) |
| PT (1) | PT96368B (lv) |
| RU (1) | RU2049784C1 (lv) |
| SK (1) | SK278810B6 (lv) |
| TW (1) | TW215921B (lv) |
| UA (1) | UA35546C2 (lv) |
| WO (1) | WO1991009857A1 (lv) |
| ZA (1) | ZA9010447B (lv) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9127304D0 (en) * | 1991-12-23 | 1992-02-19 | Boots Co Plc | Therapeutic agents |
| FR2692893B1 (fr) * | 1992-06-24 | 1994-09-02 | Sanofi Elf | Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. |
| GB9312893D0 (en) * | 1993-06-22 | 1993-08-04 | Boots Co Plc | Therapeutic agents |
| FR2714059B1 (fr) * | 1993-12-21 | 1996-03-08 | Sanofi Elf | Dérivés amino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. |
| FR2728901B1 (fr) * | 1994-12-28 | 1997-03-28 | Sanofi Sa | Derives de phenyl-4-thiazoles substitues, procede pour leur preparation et compositions pharmaceutiques les contenant |
| US5795905A (en) * | 1995-06-06 | 1998-08-18 | Neurocrine Biosciences, Inc. | CRF receptor antagonists and methods relating thereto |
| FR2735777B1 (fr) * | 1995-06-21 | 1997-09-12 | Sanofi Sa | Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant |
| TR199801244T2 (xx) * | 1995-12-29 | 1998-12-21 | Boehringer Ingelheim Pharmaceuticals, Inc. | Herpese kar�� �zellikler ta��yan fenil tiyazol t�revleri. |
| US6288091B1 (en) | 1995-12-29 | 2001-09-11 | Boehringer Ingelheim Ltd. | Antiherpes virus compounds and methods for their preparation and use |
| ZA9756B (en) * | 1996-01-16 | 1997-07-17 | Warner Lambert Co | Process for preparing 4,6-disubstituted pyrido[3,4-d]-pyrimidines |
| FR2754258B1 (fr) * | 1996-10-08 | 1998-12-31 | Sanofi Sa | Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant |
| US6057340A (en) * | 1998-02-03 | 2000-05-02 | American Home Products Corporation | Oxazole derivatives as serotonin-1A receptor agonists |
| FR2776925B3 (fr) * | 1998-04-07 | 2000-05-26 | Sanofi Sa | Utilisation de derives d'aminothiazole pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation |
| US6242448B1 (en) | 1998-12-17 | 2001-06-05 | American Home Products Corporation | Trisubstituted-oxazole derivatives as serotonin ligands |
| WO2002083863A2 (en) | 2001-04-17 | 2002-10-24 | Sepracor, Inc. | Thiazole and other heterocyclic ligands and use thereof |
| US6670071B2 (en) * | 2002-01-15 | 2003-12-30 | Quallion Llc | Electric storage battery construction and method of manufacture |
| US7820704B2 (en) * | 2004-04-20 | 2010-10-26 | Transtech Pharma, Inc. | Substituted heteroaryl derivatives, compositions, and methods of use |
| WO2008050821A1 (en) | 2006-10-19 | 2008-05-02 | Takeda Pharmaceutical Company Limited | Indole compound |
| MX2009012749A (es) | 2007-05-25 | 2010-03-10 | Abbott Gmbh & Co Kg | Compuestos heterociclicos como moduladores positivos del receptor de glutamato metabotropico 2 (receptor mglu2). |
| US8563742B2 (en) * | 2008-08-29 | 2013-10-22 | High Point Pharmaceuticals, Llc | Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE471555A (lv) * | 1943-06-22 | |||
| EP0149884B1 (en) * | 1983-09-09 | 1992-12-16 | Takeda Chemical Industries, Ltd. | 5-pyridyl-1,3-thiazole derivatives, their production and use |
| FR2612187B1 (fr) * | 1987-03-12 | 1989-07-21 | Sanofi Sa | Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant |
-
1989
- 1989-12-29 FR FR8917491A patent/FR2656610B1/fr not_active Expired - Fee Related
-
1990
- 1990-12-14 CZ CS906277A patent/CZ280803B6/cs not_active IP Right Cessation
- 1990-12-14 SK SK6277-90A patent/SK278810B6/sk unknown
- 1990-12-26 TW TW079110854A patent/TW215921B/zh active
- 1990-12-27 IL IL9681190A patent/IL96811A/en not_active IP Right Cessation
- 1990-12-27 PT PT96368A patent/PT96368B/pt not_active IP Right Cessation
- 1990-12-28 AU AU70555/91A patent/AU627103B2/en not_active Ceased
- 1990-12-28 IE IE472190A patent/IE67322B1/en not_active IP Right Cessation
- 1990-12-28 HU HU912819A patent/HU213230B/hu not_active IP Right Cessation
- 1990-12-28 CA CA002046883A patent/CA2046883C/en not_active Expired - Fee Related
- 1990-12-28 KR KR1019910701025A patent/KR0159517B1/ko not_active IP Right Cessation
- 1990-12-28 RU SU5001534/04A patent/RU2049784C1/ru not_active IP Right Cessation
- 1990-12-28 DE DE69017443T patent/DE69017443T2/de not_active Expired - Fee Related
- 1990-12-28 UA UA5001534A patent/UA35546C2/uk unknown
- 1990-12-28 EP EP91902715A patent/EP0462264B1/fr not_active Expired - Lifetime
- 1990-12-28 DK DK91902715.1T patent/DK0462264T3/da active
- 1990-12-28 WO PCT/FR1990/000970 patent/WO1991009857A1/fr active IP Right Grant
- 1990-12-28 PL PL90292008A patent/PL167101B1/pl not_active IP Right Cessation
- 1990-12-28 ZA ZA9010447A patent/ZA9010447B/xx unknown
- 1990-12-28 ES ES91902715T patent/ES2069276T3/es not_active Expired - Lifetime
- 1990-12-28 JP JP3502549A patent/JP2758077B2/ja not_active Expired - Fee Related
- 1990-12-28 HU HU912819A patent/HUT61761A/hu unknown
- 1990-12-28 AT AT91902715T patent/ATE119160T1/de not_active IP Right Cessation
- 1990-12-29 CN CN90110167A patent/CN1028757C/zh not_active Expired - Fee Related
-
1991
- 1991-01-04 NZ NZ236678A patent/NZ236678A/en unknown
- 1991-08-28 FI FI914058A patent/FI95380C/fi active
- 1991-08-28 NO NO913378A patent/NO179975C/no unknown
-
1992
- 1992-06-19 MX MX9203019A patent/MX9203019A/es unknown
-
1993
- 1993-08-25 US US08/111,732 patent/US5470855A/en not_active Expired - Lifetime
-
1995
- 1995-08-04 US US08/511,468 patent/US5780468A/en not_active Expired - Fee Related
-
1996
- 1996-07-18 LV LV960269A patent/LV5803B4/lv unknown
-
1997
- 1997-04-01 BR BR1100202-6A patent/BR1100202A/pt active IP Right Grant
- 1997-07-08 HK HK97101518A patent/HK1000011A1/fr not_active IP Right Cessation
-
1998
- 1998-05-20 US US09/081,782 patent/US6057318A/en not_active Expired - Fee Related
- 1998-05-20 US US09/081,783 patent/US5891894A/en not_active Expired - Fee Related
- 1998-05-20 US US09/081,669 patent/US5891893A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LV5803B4 (lv) | Heterocikliskie atvasinajumi to iegusanas panemiens un to terapeitiska izmantosana par PAF-antagonistu | |
| RU93044129A (ru) | Разветвленные алкиламино-производные тиазола, способ их получения, применения и содержащие их фармацевтические композиции | |
| ES472659A1 (es) | Un procedimiento para la preparacion de nuevos derivados aminicos de polioles | |
| YU60198A (sh) | Supstituisani derivati indazola i njihova upotreba kao fosfodiesteraze (pde) tipa iv i inhibitora faktora nekroze tumora (tnf) | |
| ES8705393A1 (es) | Un procedimiento para preparar un derivado de pirazol (como divisional de la solicitud de patente de invencion n 543.046, presentada el 10.5.85) | |
| KR880009910A (ko) | 리폭시게네이즈 억제 화합물 | |
| ES513469A0 (es) | Procedimiento para preparar derivados de pirimidona. | |
| EA199801028A1 (ru) | Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний | |
| DK160686A (da) | Tri- og tetracycliske forbindelser | |
| BG106847A (en) | Substituted piperazine derivatives as mtp inhibitors | |
| ES8707502A1 (es) | Procedimiento para la preparacion de -aminocarbonil-1-ben- cil-3,4-dihidro-isoquinoleinas | |
| SE8101311L (sv) | Heterocykliska foreningar | |
| IL62906A (en) | Phenylpropylamine derivatives,their preparation and their use as fungicides | |
| NO821841L (no) | Mettede aminocyklitderivater, deres fremstilling og legemiddel inneholdende dem | |
| CO4700285A1 (es) | Derivados de 1-oxo-2-(fenilsulfonilamino)pentilpiperidina, su preparacion y su aplciacion en la terapeutica | |
| FI80878B (fi) | Foerfarande foer framstaellning av farmakologiskt anvaendbara -aryl- -pyridylalkansyraderivat. | |
| SE8100237L (sv) | Imidazol-hydrazon-derivat | |
| NO820180L (no) | Basisk substituert antranilsyrer, fremgangsmaate til deres fremstilling og deres anvendelse | |
| EA199800677A1 (ru) | Способ ингибирования опухоли толстой кишки | |
| TW257759B (en) | Piperazine derivatives (2) | |
| JPS5321132A (en) | Propanol derivatives and their preparation | |
| FR2411834A1 (fr) | Nouveaux derives de 2-aryl-1h-perimidine et leur utilisation therapeutique | |
| ES461254A1 (es) | Un procedimiento para la preparacion de derivados de 1,4-di-hidropiridina. | |
| ES298221A1 (es) | Procedimiento para la preparacion de un agente fungicida |